Alfuzosin is available as a generic drug and as a brand-name drug. Brand name: Uroxatral. Alfuzosin only comes as an extended-release oral tablet. Alfuzosin is used to treat benign prostatic ...

This randomized, double-blind, placebo-controlled study was conducted at 52 sites in the United States from 10 January 2003 to 18 August 2003. An amendment to the original study protocol, made on 22 ...

Review the side-effects of Alfuzosin as documented in medical literature. The term "side effects" refers to unintended effects that can occur as a result of taking the medication. In majority of the ...

Discover comprehensive details about Alfuzosin, including its pronunciation, uses, dosage instructions, indications, and guidelines on how and when to take it or avoid it. The updated prescription ...

The volume of distribution of alfuzosin is 2.5 L/kg, and 90% of each dose is protein bound. Because the volume of distribution of alfuzosin is lower in some elderly patients, the initial dose in these ...

BARCELONA—Alfuzosin 10 mg once-daily (OD) improves ejaculatory dysfunction in sexually active men with lower urinary tract symptoms (LUTS) suggestive of benign prostatic hyperplasia (BPH), according ...

Two new studies have confirmed that a subset of α 1-blockers, including alfuzosin, combat sexual dysfunction while relieving the lower urinary tract symptoms (LUTS) associated with benign prostatic ...

In men with chronic prostatitis–chronic pelvic pain syndrome, treatment with alpha-adrenergic receptor blockers early in the course of the disorder has been reported to be effective in some, but not ...

Please provide your email address to receive an email when new articles are posted on . WASHINGTON — Alfuzosin, an alpha1 receptor antagonist, helped decrease anal pressure in women with constipation, ...

Use of alfuzosin 10 mg once daily increases the likelihood of a successful trial without catheter (TWOC) after acute urinary retention (AUR) secondary to benign prostatic hyperplasia (BPH), according ...

Benign prostatic hyperplasia (BPH) is a condition in which a man’s prostate enlarges abnormally due to an overgrowth of prostate tissue. When the prostate enlarges, it pushes against the urethra and ...

The Food and Drug Administration (FDA) is reviewing an ER formulation of alfuzosin hydrochloride 10 mg for once-daily administration for treatment of symptomatic BPH. The IR and twice-daily ER ...